YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs.

Launched by EUROPEAN INSTITUTE OF ONCOLOGY · Mar 22, 2024

Keywords

ClinConnect Summary

The YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs trial is a research study looking to better understand cancers that affect young adults, especially those aged 18 to 39. The goal of this trial is to collect biological samples, such as blood or tissue, from participants to help identify specific markers that could predict how these cancers behave and how patients might respond to treatments. This is important because young adults with cancer often have unique challenges and needs that haven’t been fully addressed in previous research.

To be eligible for this study, participants must be diagnosed with certain types of cancer, including various forms of gastrointestinal cancer and neuroendocrine tumors, within the last two years. The trial is open to all genders and includes patients at any stage of their disease. Those who join the study can expect to contribute to important research that may improve understanding and treatment options for young adults facing these serious conditions. This trial is currently recruiting participants, so if you or someone you know fits the criteria, it may be a valuable opportunity to help advance cancer research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age at diagnosis from18 to 39 years of age
• • Carcinoma (without limitations for histologic subtypes) from any primary sites: esophagus, stomach, pancreas, biliary tract, liver, small bowel, colon, rectum, anus and cancer of unknown origin
• • Neuroendocrine neoplasm (NEN) from Gastroenteropancreatic GEP or lung/thymus origin
• • Tumors at any stage at the first visit
• • Tumors of any grade
• • Histological diagnosis obtained within two years from the time of enrollment or willingness to undergo bioptic procedure for diagnosis
• Exclusion Criteria:
• • Age at diagnosis \> 39 years old